Cancer drug prices to fall, with about ₹3,540 crore in expected relief
Prices of several cancer medicines are set to come down, a change expected to save patients and the health system roughly ₹3,540 crore. The reduction is intended to make essential oncology treatments more affordable for those who depend on them. The article attributes the expected relief to the move toward lower-cost pricing for these drugs. Because the full details of implementation were not provided in the source text, the scope and timing of the savings remain uncertain.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in